Prudential Financial Inc. Has $14.59 Million Holdings in Waters Corporation $WAT

Prudential Financial Inc. raised its stake in Waters Corporation (NYSE:WAT) by 7.7% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 41,795 shares of the medical instruments supplier’s stock after buying an additional 2,971 shares during the quarter. Prudential Financial Inc. owned 0.07% of Waters worth $14,588,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in WAT. Charles Schwab Investment Management Inc. increased its stake in shares of Waters by 4.2% in the 2nd quarter. Charles Schwab Investment Management Inc. now owns 432,530 shares of the medical instruments supplier’s stock valued at $150,970,000 after acquiring an additional 17,461 shares during the last quarter. Mufg Securities Americas Inc. grew its holdings in Waters by 25.4% during the second quarter. Mufg Securities Americas Inc. now owns 1,319 shares of the medical instruments supplier’s stock valued at $460,000 after purchasing an additional 267 shares during the period. Evelyn Partners Asset Management Ltd increased its stake in Waters by 329.5% in the second quarter. Evelyn Partners Asset Management Ltd now owns 47,132 shares of the medical instruments supplier’s stock valued at $16,451,000 after purchasing an additional 36,158 shares in the last quarter. DNB Asset Management AS increased its stake in Waters by 7.3% in the second quarter. DNB Asset Management AS now owns 11,016 shares of the medical instruments supplier’s stock valued at $3,845,000 after purchasing an additional 747 shares in the last quarter. Finally, Entropy Technologies LP raised its holdings in Waters by 30.7% in the second quarter. Entropy Technologies LP now owns 784 shares of the medical instruments supplier’s stock worth $274,000 after purchasing an additional 184 shares during the period. Institutional investors own 94.01% of the company’s stock.

Waters Stock Performance

WAT opened at $407.53 on Thursday. The company has a market capitalization of $24.26 billion, a price-to-earnings ratio of 36.75, a P/E/G ratio of 3.19 and a beta of 1.11. The business’s 50-day moving average price is $346.20 and its two-hundred day moving average price is $330.09. Waters Corporation has a 1 year low of $275.05 and a 1 year high of $423.56. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.75 and a quick ratio of 1.22.

Waters (NYSE:WAT) last posted its quarterly earnings data on Thursday, May 19th. The medical instruments supplier reported $2.29 earnings per share (EPS) for the quarter. The business had revenue of $608.55 million during the quarter. Waters had a return on equity of 38.60% and a net margin of 21.71%. Equities analysts expect that Waters Corporation will post 12.86 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the stock. TD Cowen boosted their price target on shares of Waters from $345.00 to $390.00 and gave the company a “hold” rating in a report on Wednesday, November 5th. JPMorgan Chase & Co. lifted their target price on Waters from $300.00 to $325.00 and gave the stock a “neutral” rating in a report on Thursday, October 9th. Jefferies Financial Group set a $385.00 target price on Waters and gave the company a “buy” rating in a research note on Monday, August 4th. Cowen reaffirmed a “hold” rating on shares of Waters in a research report on Wednesday, November 5th. Finally, Redburn Partners set a $390.00 price objective on Waters in a research report on Wednesday, October 8th. Two analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $381.57.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.